Peer-reviewedCC BY-NC-NDIScience
HDAC inhibitor treatment restores transcriptome, chromatin accessibility, and memory deficits in a mouse model for Down syndrome
Related
- A druggable chromatin vulnerability in suppressive neutrophils restores antitumor immunity
- FHL1 Downregulation Is Specific to Cancer-Associated Fibroblasts and Linked to Reduced Chromatin Accessibility in Colorectal Cancer.
- SUMO2 deletion changes chromatin accessibility and enhances cytotoxic T cell activation and tumor infiltration
- Genetic regulation of cell type–specific chromatin accessibility contributes to migraine etiology
- MAPK signaling links BRD2 chromatin occupancy to PI3K/AKT inhibitor sensitivity
BibTeX
@article{sierra2026hdac,
title = {{HDAC inhibitor treatment restores transcriptome, chromatin accessibility, and memory deficits in a mouse model for Down syndrome}},
author = {Cesar Sierra and René A.J. Crans and Mara Dierssen},
journal = {IScience},
year = {2026},
month = sep,
doi = {10.1016/j.isci.2026.117670},
url = {https://europepmc.org/article/PMC/PMC13657111},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - HDAC inhibitor treatment restores transcriptome, chromatin accessibility, and memory deficits in a mouse model for Down syndrome
AU - Cesar Sierra
AU - René A.J. Crans
AU - Mara Dierssen
PY - 2026
DA - 2026/09/30
JO - IScience
DO - 10.1016/j.isci.2026.117670
UR - https://europepmc.org/article/PMC/PMC13657111
SN - 2589-0042
ER -